Overexpression of SHANK2 relates to tumor malignant potential and outcomes of gastric cancer.

被引：0
|
作者：
Arakawa, Hiroshi [1 ]
Komatsu, Shuhei [1 ]
Kamiya, Hajime [1 ]
Hamada, Satoshi [1 ]
Yamauchi, Masateru [1 ]
Ishida, Ryo [1 ]
Nishibeppu, Keiji [1 ]
Kiuchi, Jun [1 ]
Imamura, Taisuke [1 ]
Konishi, Hirotaka [1 ]
Shiozaki, Atsushi [1 ]
Kubota, Takeshi [1 ]
Fujiwara, Hitoshi [1 ]
Tsuda, Hitoshi [2 ]
Otsuji, Eigo [1 ]
机构：
[1] Kyoto Pref Univ Med, Div Digest Surg, Kyoto, Japan
[2] Natl Def Med Coll, Invest Pathol, Tokorozawa, Saitama, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1013
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] Resveratrol: A potential chemopreventive agent in human gastric cancer.
    Atten, MJ
    Attar, BM
    Holian, O
    GASTROENTEROLOGY, 1998, 114 (04) : A560 - A560
  • [42] MET amplification as a potential therapeutic target in gastric cancer.
    Kawakami, Hisato
    Okamoto, Isamu
    Arao, Tokuzo
    Okamoto, Wataru
    Matsumoto, Kazuko
    Taniguchi, Hirokazu
    Kuwata, Kiyoko
    Yamaguchi, Haruka
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    Yamada, Yasuhide
    CANCER RESEARCH, 2013, 73 (08)
  • [43] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Li Wei
    Liang Tang
    Haiyan Chang
    Song Huo
    Yan Li
    Human Cell, 2020, 33 : 116 - 122
  • [44] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Wei, Li
    Tang, Liang
    Chang, Haiyan
    Huo, Song
    Li, Yan
    HUMAN CELL, 2020, 33 (01) : 116 - 122
  • [45] Overexpression of humbug promotes malignant progression in human gastric cancer cells
    Lee, Jeong-Hyung
    ONCOLOGY REPORTS, 2008, 19 (03) : 795 - 800
  • [46] The role of serial circulating tumor DNA for predicting clinical outcomes of chemotherapy in patients with advanced gastric cancer.
    Kim, Sheehyun
    Lim, Yoojoo
    Kang, Jun-Kyu
    Kim, Hwang-Phill
    Kim, Tae-You
    Kim, Tae-Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 433 - 433
  • [47] Lack of overexpression of cyclooxygenase-2 in prostate cancer.
    Zha, S
    Sauvageot, J
    Ewing, C
    Gage, WR
    De Marzo, AM
    Isaacs, WB
    LABORATORY INVESTIGATION, 2001, 81 (01) : 130A - 130A
  • [48] Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer.
    Cho, Jang Ho
    Lim, Sung Won
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [49] Lack of overexpression of cyclooxygenase-2 in prostate cancer.
    Zha, S
    Sauvageot, J
    Ewing, C
    Gage, WR
    De Marzo, AM
    Isaacs, WB
    MODERN PATHOLOGY, 2001, 14 (01) : 130A - 130A
  • [50] Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
    Togashi, Yosuke
    Tada, Yasuko
    Kotani, Daisuke
    Kawazoe, Akihito
    Doi, Toshihiko
    Nishikawa, Hiroyoshi
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
12345